Patents by Inventor Pierre Perreaut

Pierre Perreaut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMBINATIONS FOR TREATING ACUTE MYELOID LEUKAEMIA OR CHRONIC MYELOID LEUKAEMIA
    Publication number: 20150005253
    Abstract: The present disclosure relates to combinations of N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-N?-(1,1-dimethylethyl)-urea and cytarabine and their use for treating AML or CML.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 1, 2015
    Inventors: Bernard BOURRIE, Pierre CASELLAS, Sylvie COSNIER-PUCHEU, Samir JEGHAM, Pierre PERREAUT
  • Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same
    Patent number: 8008310
    Abstract: Derivatives of pyrido[2,3-d]pyrimidine are provided having formula (I) with Ar1, Ar2 and R1 as defined herein, which are useful for treating cell proliferative conditions, and to the preparation thereof, and to the therapeutic application of the same.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: August 30, 2011
    Assignee: Sanofi-Aventis
    Inventors: Bernard Bourrie, Pierre Casellas, Samir Jegham, Claude Muneaux, Pierre Perreaut
  • Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof
    Patent number: 7893259
    Abstract: The disclosure concerns pyrido[2,3-d]pyrimidine derivatives, their preparation and their therapeutic application, of general formula (I): and acid addition salts, hydrates and solvates thereof, as well as in the form of enantiomers, diastereoisomers and mixtures thereof. The disclosure also concerns methods for preparing said derivatives, pharmaceutical compositions containing a compound of general formula (I), and their therapeutic use.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: February 22, 2011
    Assignee: Sanofi-Aventis
    Inventors: Bernard Bourrie, Pierre Casellas, Samir Jegham, Pierre Perreaut
  • Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof
    Patent number: 7842806
    Abstract: The disclosure relates to pyrido[2,3-d]pyrimidone compounds, to the preparation thereof and to the therapeutic use thereof, wherein said compounds are of general formula (I): in the form of a base or of an addition salt with an acid which is pharmaceutically acceptable, in the form of hydrates or of solvates, and also in the form of enantiomers, diastereoisomers and a mixture thereof. The disclosure also relates to processes for preparing said compounds, to pharmaceutical compositions containing a compound of general formula (I), and to the therapeutic use of said compounds and compositions.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: November 30, 2010
    Assignee: sanofi-aventis
    Inventors: Pierre Perreaut, Samir Jegham, Bernard Bourrie, Pierre Casellas, Jean-Robert Labrosse, Florence Durand
  • PYRIDO-PYRIMIDINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF
    Publication number: 20090233923
    Abstract: The disclosure concerns pyrido[2,3-d]pyrimidine derivatives, their preparation and their therapeutic application, of general formula (I): and acid addition salts, hydrates and solvates thereof, as well as in the form of enantiomers, diastereoisomers and mixtures thereof. The disclosure also concerns methods for preparing said derivatives, pharmaceutical compositions containing a compound of general formula (I), and their therapeutic use.
    Type: Application
    Filed: March 31, 2009
    Publication date: September 17, 2009
    Applicant: Sanofi-aventis
    Inventors: Bernard Bourrie, Pierre Casellas, Samir Jegham, Pierre Perreaut
  • Derivatives of Pyrido[2,3-d]pyrimidine, the Preparation Thereof, and the Therapeutic Application of the Same
    Publication number: 20090163522
    Abstract: The invention relates to derivatives of pyrido[2,3-d]pyrimidine, to the preparation thereof, and to the therapeutic application of the same.
    Type: Application
    Filed: January 30, 2009
    Publication date: June 25, 2009
    Applicant: sanofi-aventis
    Inventors: Bernard BOURRIE, Pierre CASELLAS, Samir JEGHAM, Claude MUNEAUX, Pierre PERREAUT
  • Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof
    Patent number: 7544682
    Abstract: The disclosure concerns pyrido[2,3-d]pyrimidine derivatives, their preparation and their therapeutic application, of general formula (I) and acid addition salts, hydrates and solvates thereof, as well as in the form of enantiomers, diastereoisomers and mixtures thereof. The disclosure also concerns methods for preparing said derivatives, pharmaceutical compositions containing a compound of general formula (I), and their therapeutic use.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: June 9, 2009
    Assignee: Sanofi-Aventis
    Inventors: Bernard Bourrie, Pierre Casellas, Samir Jegham, Pierre Perreaut
  • Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same
    Patent number: 7504406
    Abstract: The invention relates to derivatives of pyrido[2,3-d]pyrimidine, to the preparation thereof, and to the therapeutic application of the same.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: March 17, 2009
    Assignee: Sanofi-Aventis
    Inventors: Bernard Bourrie, Pierre Casellas, Samir Jegham, Claude Muneaux, Pierre Perreaut
  • PYRIDOPYRIMIDONE DERIVATIVES, PREPARATION THEREOF, THERAPEUTIC USE THEREOF
    Publication number: 20090048277
    Abstract: The disclosure relates to pyrido[2,3-d]pyrimidone compounds, to the preparation thereof and to the therapeutic use thereof, wherein said compounds are of general formula (I): in the form of a base or of an addition salt with an acid which is pharmaceutically acceptable, in the form of hydrates or of solvates, and also in the form of enantiomers, diastereoisomers and a mixture thereof. The disclosure also relates to processes for preparing said compounds, to pharmaceutical compositions containing a compound of general formula (I), and to the therapeutic use of said compounds and compositions.
    Type: Application
    Filed: July 2, 2008
    Publication date: February 19, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Pierre PERREAUT, Samir JEGHAM, Bernard BOURRIE, Pierre CASELLAS, Jean-Robert LABROSSE, Florence DURAND
  • Derivatives of Pyrido[2,3-d]pyrimidine, the Preparation Thereof, and the Therapeutic Application of the Same
    Publication number: 20080176874
    Abstract: The invention relates to derivatives of pyrido[2,3-d]pyrimidine, to the preparation thereof, and to the therapeutic application of the same.
    Type: Application
    Filed: December 13, 2007
    Publication date: July 24, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Bernard BOURRIE, Pierre CASELLAS, Samir JEGHAM, Claude MUNEAUX, Pierre PERREAUT
  • Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof
    Publication number: 20070167469
    Abstract: The disclosure concerns pyrido[2,3-d]pyrimidine derivatives, their preparation and their therapeutic application, of general formula (I) and acid addition salts, hydrates and solvates thereof, as well as in the form of enantiomers, diastereoisomers and mixtures thereof. The disclosure also concerns methods for preparing said derivatives, pharmaceutical compositions containing a compound of general formula (I), and their therapeutic use.
    Type: Application
    Filed: January 8, 2007
    Publication date: July 19, 2007
    Applicant: Sanofi-aventis
    Inventors: Bernard Bourrie, Pierre Casellas, Samir Jegham, Pierre Perreaut
  • Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
    Patent number: 7157454
    Abstract: The invention relates to compounds of formula: These compounds show affinity for the bradykinin receptors with selectivity towards the B1 receptors; they may be used for the preparation of medicinal products intended for treating or preventing inflammation pathologies and persistent or chronic inflammatory diseases.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: January 2, 2007
    Assignee: Sanofi-Aventis
    Inventors: Bernard Ferrari, Jean Gougat, Yvette Muneaux, Pierre Perreaut, Lionel Sarran
  • Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
    Publication number: 20040116353
    Abstract: The invention relates to compounds of formula: 1
    Type: Application
    Filed: September 18, 2003
    Publication date: June 17, 2004
    Inventors: Bernard Ferrari, Jean Gougat, Yvette Muneaux, Pierre Perreaut, Lionel Sarran
  • N-(arylsulphonyl) amino acid derivatives
    Patent number: 6610882
    Abstract: The invention relates to compounds of formula in which R1 to R9, R16 and R17 are as defined in claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: August 26, 2003
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Publication number: 20030073641
    Abstract: The invention relates to compounds of formula 1
    Type: Application
    Filed: June 7, 2002
    Publication date: April 17, 2003
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Publication number: 20020115685
    Abstract: The invention relates to compounds of formula 1
    Type: Application
    Filed: September 6, 2001
    Publication date: August 22, 2002
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Patent number: 6433185
    Abstract: The invention relates to compounds of formula in which R1 to R9, R16 and R17 are as defined in claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: August 13, 2002
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulfonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Patent number: 6313120
    Abstract: The invention relates to compounds of formula in which R1 to R9, R16 and R17 are as defined in Claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: November 6, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
    Patent number: 6100278
    Abstract: The invention relates compounds of formula ##STR1## in which R.sub.1 to R.sub.9, R.sub.16 and R.sub.17 are as defined in claim 1.These compounds are pharmacologically active.
    Type: Grant
    Filed: November 4, 1999
    Date of Patent: August 8, 2000
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault
  • N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity
    Patent number: 6015812
    Abstract: The invention relates to compounds of formula ##STR1## in which R.sub.1 to R.sub.9, R.sub.16 and R.sub.17 are defined in claim 1. These compounds are pharmacologically active.
    Type: Grant
    Filed: July 2, 1998
    Date of Patent: January 18, 2000
    Assignee: Sanofi-Synthelabo
    Inventors: Bernard Ferrari, Jean Gougat, Claude Muneaux, Yvette Muneaux, Pierre Perreaut, Claudine Planchenault